posted on 2019-03-28, 00:00authored byYifei Hu, Yunci Qi, Spencer D. Stumpf, John M. D’Alessandro, Joshua A. V. Blodgett
Piperazate
(Piz) is a nonproteinogenic amino acid noted for its
unusual N–N bond motif. Piz is a proline mimic that imparts
conformational rigidity to peptides. Consequently, piperazyl molecules
are often bioactive and desirable for therapeutic exploration. The in vitro characterization of Kutzneria enzymes
KtzI and KtzT recently led to a biosynthetic pathway for Piz. However,
Piz anabolism in vivo has remained completely uncharacterized.
Herein, we describe the systematic interrogation of actinobacterial
Piz metabolism using a combination of bioinformatics, genetics, and
select biochemistry. Following studies in Streptomyces flaveolus, Streptomyces lividans, and several environmental Streptomyces isolates, our data suggest that KtzI-type enzymes
are conditionally dispensable for Piz production. We also demonstrate
the feasibility of Piz monomer production using engineered actinobacteria
for the first time. Finally, we show that some actinobacteria employ
fused KtzI–KtzT chimeric enzymes to produce Piz. Our findings
have implications for future piperazyl drug discovery, pathway engineering,
and fine chemical bioproduction.